





Background: Cranioplasty for the treatment of cephalhematomas in small infants with limit-
ed blood volume is challenging because of massive bleeding. This study aimed to elucidate 
the correlation between cephalhematoma size and intraoperative blood loss and identify cri-
teria that can predict large intraoperative blood loss. 
Methods: We reviewed the medical records of 120 pediatric patients aged less than 24 
months who underwent cranioplasty for treatment of a cephalhematoma. The cephalhema-
toma sizes in preoperative brain computed tomography (CT) were measured using ImageJ. 
Results: Pearson correlation showed that the cephalhematoma size in the pre-operative 
brain CT was weakly correlated with intraoperative blood loss (Pearson coefficient = 0.192, 
P = 0.037). In a multivariable logistic regression analysis, a cephalhematoma size greater 
than 113.5 cm3 was found to be a risk factor for large blood loss. The area under the curve 
in the receiver operating characteristic plot of the multivariable model was 0.714 (0.619–
0.809). 
Conclusions: A cephalhematoma size cutoff value of 113.5 cm3, as measured in the preop-
erative CT imaging, can predict intraoperative blood loss exceeding 30% of the total body 
blood volume. The establishment of a transfusion strategy prior to surgery based on cephal-
hematoma size could be useful in pediatric cranioplasty. 
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INTRODUCTION 
A cephalhematoma, which is a collection of blood be-
tween the skull and the periosteum, usually occurs in the 
neonatal period as a result of birth trauma. In most cases, 
the cephalhematoma is self-absorbed within 4 weeks; 
however, if it is not absorbed within this period, delayed 
ossification or calcification occurs [1]. The treatment of os-
sified cephalhematomas is controversial, and conservative 
treatment is recommended because of the possibility of 
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natural absorption within 3–6 months. However, surgical 
treatment is required to prevent the development of asym-
metry and skull deformities due to large cephalhematomas 
[2]. Cosmetic reasons are another indication for surgical 
treatment [3]. Performing surgery in patients at an early 
age, approximately 2 months old, is technically easy, and it 
provides the advantage of obtaining good head shape due 
to natural molding [4]. 
However, small infants with limited total blood volume 
might become hemodynamically unstable even with a rel-
atively small amount of intraoperative bleeding. Along with 
the monitoring of vital signs and hemoglobin levels, visual 
estimation of blood loss in the surgical field is essential, but 
it is often inaccurate and unreliable [5]. Anesthesiologists 
should consider the possibility of massive bleeding and es-
tablish a fluid and transfusion strategy prior to the start of 
surgery. Total body blood volume should be an important 
consideration when deciding to perform transfusion in pe-
diatric patients undergoing craniofacial surgery [6]. Thus, 
the prediction of intraoperative large blood loss based on 
the total body blood volume prior to surgery could be ad-
vantageous in establishing intraoperative transfusion strat-
egies. 
In this study, we measured the size of cephalhematomas 
in preoperative computed tomography (CT) images to elu-
cidate the correlation between the cephalhematoma size 
and intraoperative blood loss. Additionally, we attempted 
to identify a cephalhematoma size cutoff value that can 
predict intraoperative blood loss exceeding 30% of the total 
body blood volume. 
MATERIALS AND METHODS 
Study population and data collection 
The study protocol was approved by the Institutional Re-
view Board of the University Health System, Seoul, South 
Korea (no. 4-2018-0701). Since the study involved retro-
spective review of patient medical records, the need for in-
formed consent was waived. The medical records of pedi-
atric patients aged less than 24 months who underwent 
cranioplasty for a cephalhematoma between January 2008 
and March 2018 were retrospectively reviewed. During this 
period, the surgical procedure was performed by two sur-
geons. Linear skin incision is made on the longest dimen-
sion of the ossified mass. The pericranium is preserved for 
postoperative bony healing. Abnormal bony mass is re-
moved using rongeur and high-speed drill to smoothen the 
edge of the bony mass. Bone bleeding is controlled using 
bone wax. Drainage catheter is inserted, and skin closure is 
done using absorbable monofilament suture in a subcutic-
ular fashion. The exclusion criteria were as follows: age >  
24 months, a previously diagnosed bleeding disorder, and 
insufficient medical data. 
The following preoperative data were assessed: demo-
graphic data, laboratory data (hemoglobin, hematocrit, 
and platelet levels; prothrombin time; and international 
normalized ratio), and any preexisting conditions, includ-
ing a history of congenital heart disease or neonatal jaun-
dice. The assessed intraoperative data included duration of 
surgery, duration of anesthesia, intraoperative fluid amount, 
amount of packed red blood cells transfused, blood loss, 
urine output, intraoperative hypotension, severe hypoten-
sion, and vasopressor use. The following postoperative data 
were assessed: laboratory data (hemoglobin and hematocrit 
levels), postoperative transfusion of packed red blood cell 
or freshly frozen plasma, and duration of the postoperative 
hospital stay. Hypotension was defined as a 20% reduction 
in systolic blood pressure from baseline [7]; more than 50% 
reduction in systolic blood pressure from baseline was 
considered severe hypotension.  
Patients were divided into two groups: large blood loss 
group and small blood loss group. Patients whose intraop-
erative bleeding exceeded 30% of the total body blood vol-
ume were classified as the large blood loss group. All others 
were classified into the small blood loss group. The esti-
mated blood volume (ml) was calculated by multiplying 
the body weight (kg) by 80 ml. 
Each patient in this study underwent a preoperative 
brain CT for a cephalhematoma, and the size of the cephal-
hematoma was measured using ImageJ (version 1.33, U.S. 
National Institutes of Health, USA). Brain CT images were 
opened in ImageJ and the cephalhematomas were manu-
ally outlined on each slice (Fig. 1). The area of each hema-
toma was multiplied by the slice thickness to calculate the 
total volume. 
Statistical analysis 
Descriptive data are presented as mean values ±  SD, or 
median (1Q, 3Q). For intergroup comparisons, the chi-
square test or Fisher’s exact test was used for categorical 
variables and Student’s t-test or the Wilcoxon-Mann-Whit-








relation was used to determine the relationship between 
the two continuous variables. The binary response of the 
blood loss groups was analyzed by multivariable logistic 
regression in terms of explanatory variables: cephalhema-
toma size, age (months), weight, and American Society of 
Anesthesiologists’ physical status. We determined the cut-
off value of the cephalhematoma size that maximized the 
area under the curve (AUC) when divided into two catego-
ries. Statistical analyses were performed using SPSS Statis-
tics 23 (IBM SPSS Statistics for Windows, IBM Corp., USA), 
SAS (version 9.4, SAS Inc., USA), and R version 3.5.1 (The R 
Foundation for Statistical Computing, Austria). 
RESULTS 
A total of 123 pediatric patients underwent cranioplasty 
as treatment of a cephalhematoma from January 2008 to 
March 2018. Two patients aged >  24 months and one pa-
tient with incomplete data were excluded, and the remain-
ing 120 patients were analyzed in this study. Of the final 
120 patients analyzed, 32 were classified into the large 
blood loss group and 88 patients were classified into the 
small blood loss group. 
Demographics 
Demographic data including age, body weight, and 
American Society of Anesthesiologists physical status were 
similar between the two groups; however the cephalhema-
toma size was higher in the large blood loss group than in 
the small blood loss group. While the incidence of intraop-
erative hypotension and atropine use were comparable be-
tween the two groups, the duration of surgery, amount of 
intraoperative packed red blood cells transfused, and the 
occurrence of severe hypotension were higher in the large 
blood loss group than in the small blood loss group. While 
the hemoglobin and hematocrit levels decreased during 
surgery in the small blood loss group (both P =  0.002), the 
change in the hemoglobin and hematocrit levels in the 
large blood loss group was not statistically different (P =  
0.067 and P =  0.081, respectively). Postoperative transfu-
sion and the length of hospital stay after surgery were com-
parable between the two groups (Table 1). 
Relationship between cephalhematoma size and 
blood loss 
Pearson correlation showed that the cephalhematoma 
size measured in the preoperative brain CT scan was cor-
related with intraoperative blood loss (P =  0.037); however, 
the correlation between the two variables was weak (Pear-
son coefficient =  0.192; Fig. 2A). Cephalhematoma size 
was also weakly correlated with the amount of packed red 
blood cells transfused (Pearson coefficient =  0.273, P =  
0.003; Fig. 2B).  
Cephalhematoma size as a risk factor for large 
blood loss  
In the multivariable regression analysis, only age was 
found to be a risk factor for large blood loss (Table 2). The 
cephalhematoma size was transformed into a binary vari-
able using a cutoff value of 113.5 cm3 obtained by maximiz-
ing the AUC (Fig. 3A). In a multivariable logistic regression 
analysis with categorized cephalhematoma size as the vari-
able, a cephalhematoma size greater than 113.5 cm3 was 
found to be a risk factor for large blood loss (Table 3). The 
AUC in the ROC plot of the multivariable model was 0.714 
(0.619–0.809) (Fig. 3B). 
DISCUSSION 
This study showed that cephalhematoma size measured 
in the preoperative CT images was linearly correlated with 
intraoperative blood loss. Furthermore, multivariable lo-
gistic regression analysis revealed that a cephalhematoma 
size greater than 113.5 cm3 was an independent risk factor 
for large blood loss during cranioplasty. 
One of the most common causes of cardiac arrest during 
pediatric surgery is hypovolemia due to intraoperative 
bleeding, and it often occurs in craniofacial surgery [8]. 
Therefore, meticulous fluid management is required for 
Fig. 1. Brain computed tomography images opened in ImageJ.
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Table 1. Patient Demographics and Clinical Data
Variable Small blood loss group (n =  88) Large blood loss group (n =  32) P value
Cephalhematoma size (cm3) 75.1 (41.8, 119.2) 115.1 (49.7, 197.3) 0.025
Age (mo) 4 (3, 5) 4 (3, 5) 0.491
Weight (kg) 7.4 (6.7, 8.3) 7.1 (6.3, 8.0) 0.155
Duration of surgery (min) 64.0 (52.0, 82.0) 77.5 (71.3, 91.3) 0.001
Duration of anesthesia (min) 125.0 (105.0, 138.8) 130.0 (110.0, 145.0) 0.076
ASA 0.657
 1 84 (95.5) 30 (93.8)
 2, 3 4 (4.5) 2 (6.3)
Intraoperative intake fluid (ml) 170.0 (130.0, 245.0) 280.0 (200.0, 400.0) <  0.001
Intraoperative RBC transfusion (ml) 65.0 (0.0, 120.0) 200.0 (150.0, 250.0) <  0.001
Intraoperative blood loss (ml) 100.0 (20.0, 120.0) 205.0 (200.0, 300.0) <  0.001
Intraoperative atropine use 11 (12.5) 7 (21.9) 0.249
Intraoperative epinephrine use 4 (4.5) 1 (3.1) >  0.999
Hypotension 78 (88.6) 28 (87.5) >  0.999
Severe hypotension 8 (9.1) 8 (25.0) 0.033
Preoperative hemoglobin (g/dl) 11.7 (11.2, 12.4) 11.8 (11.1, 12.5) 0.396
Postoperative hemoglobin (g/dl) 11.3 (9.9, 12.2) 12.5 (11.5, 13.6) <  0.001
Preoperative hematocrit (%) 34.5 (32.8, 36.5) 35.1 (33.0, 36.1) 0.548
Postoperative hematocrit (%) 33.1 (29.3, 36.1) 37.4 (33.9, 39.4) <  0.001
Preoperative platelet count (103/µl) 413.5 (361.3, 511.8) 422.0 (354.0, 509.3) 0.788
Preoperative prothrombin time (%) 10.7 (10.3, 11.4) 10.8 (10.2, 11.6) 0.945
Preoperative prothrombin time (INR) 0.9 (0.9, 1.0) 0.9 (0.9, 1.0) 0.714
Postoperative transfusion in POD 1 26 (29.5) 4 (12.5) 0.061
Hospital stay after surgery (d) 3.0 (2.0, 3.0) 3.0 (2.0, 3.0) 0.276
Values are presented as median (1Q, 3Q) for continuous variables and count (percentage) for categorical variables. ASA: American Society of 
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Fig. 2. Scatter plot showing the correlation between the cephalhematoma size and intraoperative blood loss (A) and that between the 
cephalhematoma size and the amount of transfusion (B).
hemodynamic stability and maintenance of major organ 
perfusion in cranioplasty for children. Thus, clinicians are 
recommended to use estimates of total blood volume to 
determine transfusion needs during pediatric craniofacial 
surgery [6]. In our study, the overall incidence of intraoper-
ative hypotension was 88.33%, and in terms of the inci-
dence of severe hypotension, the patients in the large 
blood loss group were hemodynamically more unstable 
than those in the small blood loss group. As most of the pa-










Table 2. Multivariable Logistic Regression Analysis for Intraoperative 
Bleeding Exceeding 30% of the Total Body Blood Volume
Variable Odds ratio (95% CI) P value
Cephalhematoma size (cm3) 1.004 (0.999–1.007) 0.052
Age (mo) 1.247 (1.002–1.552) 0.048
Weight (kg) 0.661 (0.415–1.051) 0.080
ASA
 1 Reference -
 2, 3 0.700 (0.094–5.212) 0.728
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Fig. 3. Receiver operating characteristic plot of the categorized 
cephalhematoma size (A), and of the multivariable model (B). Area 
under the curve: 0.635 (0.536–0.734) and 0.714 (0.619–0.809), 
respectively.
Table 3. Multivariable Logistic Regression Analysis for Intraoperative 
Bleeding Exceeding 30% of the Total Body Blood Volume with Categorized 
Cephalhematoma Volume Variables
Variable Odds ratio (95% CI) P value
Cephalhematoma size (cm3)
 <  113.5 Reference -
 >  113.5 3.692 (1.531–8.904) 0.004
Age (mo) 1.275 (1.018–1.596) 0.035
Weight (kg) 0.655 (0.408–1.053) 0.080
ASA
 1 Reference -
 2, 3 0.634 (0.075–5.348) 0.676
ASA: American Society of Anesthesiologists’ physical status, CI: 
confidence interval.
underlying medical comorbidities and since hypotension 
did not occur during the induction of general anesthesia 
but occurred during surgery, surgical bleeding was consid-
ered the main cause of hypotension in this study. Consid-
ering that the mean surgery duration was 71.2 min, a large 
amount of bleeding occurred in a short period, making he-
moglobin-based transfusion difficult. While bleeding oc-
curs in a short duration, confirming the hemoglobin level 
in the arterial blood gas analysis takes time. Therefore, as 
regards intraoperative fluid and transfusion management, 
identifying risk factors that can predict large blood loss 
based on the total body blood volume and implementing a 
transfusion strategy prior to surgery would be clinically 
useful for anesthesiologists. Cephalhematoma size larger 
than 113.5 cm3 was found to be the most important risk 
factor for large blood loss which anesthesiologists should 
carefully check before surgery. In addition to the cephalhe-
matoma size, age was another independent risk factor for 
large blood loss presumably due to the technical difficulty 
of surgery at an older age [3,4]. 
ImageJ, which we used to measure the size of the cephal-
hematoma, is a Java-based software for image processing 
developed at the National Institute of Health [9]. The accu-
racy of manual volumetry performed by clinicians using 
ImageJ on a personal computer was reported in a previous 
study based on hepatic CT [10]. Additionally, another pre-
vious study performed manual volumetry using ImageJ to 
quantify deep gray matter in the brains of infants [11]. 
Therefore, developing a transfusion strategy prior to pedi-
atric cranioplasty using cephalhematoma size measured by 
ImageJ may be helpful in maintaining hemodynamic sta-
bility during surgery. 
In previous randomized trials based on pediatric post-
surgical patients [12,13], a restrictive transfusion strategy 
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showed no increase in mortality and multiorgan dysfunc-
tion when compared with a liberal transfusion strategy. 
The mean age of the patients in these randomized trials 
varied from 26.4 to 73.7 months. Maintaining hemoglobin 
levels ≥  8 g/dl was recommended as the standard in pa-
tients with massive bleeding during surgery [6,14,15]. 
However, even in adult patients, complicated hemor-
rhage—defined as hemorrhage exceeding 30% of the total 
body blood volume—almost always causes signs of hy-
poperfusion such as hypotension and tachycardia [16,17]. 
Transfusion is usually required for this substantial blood 
loss [16]. In general, massive blood loss in acute situations 
is defined as blood loss of more than 50% of the total body 
blood volume within a period of 3 h [18,19]. Considering that 
the mean age of the patients in this study was 4.5 months, 
blood loss exceeding 30% of the total body blood volume 
within a mean surgery duration of 71.2 min almost always re-
quires blood transfusion. 
On the contrary, the initial postoperative hemoglobin 
level confirmed in the general ward or neurological inten-
sive care unit was higher in the large blood loss group than 
in the small blood loss group, which appeared to be related 
to the larger transfusion volumes required in the large 
blood loss group than in the small blood loss group. The 
short duration of massive transfusion is known to be a risk 
factor for over-transfusion [20]. However, an initial postop-
erative hematocrit level >  30% was reported to reduce the 
risk of postoperative red blood cell transfusion in pediatric 
patients undergoing craniofacial surgery [21]. Moreover, no 
patients in our study experienced over-transfusion-related 
complications, such as infection, transfusion-related acute 
lung injury, or circulatory overload [22]. 
This study has some limitations. First, as this retrospec-
tive study was based on electronic medical records, per-
forming a prospective study would be helpful in confirm-
ing a more accurate cutoff value for cephalhematoma size 
to facilitate transfusion management. Second, this study 
was based on data from a single center that was analyzed 
by two surgeons; additionally, intraoperative blood loss 
may be surgeon dependent. Thus, this result cannot be 
universally applicable to cranioplasty performed by other 
surgeons in different institutions. Third, the intraoperative 
transfusion in this study was performed without confirma-
tion of the hemoglobin level in the event of massive blood 
loss causing hemodynamic instability. Thus, the correla-
tion between the cephalhematoma size and amount of 
packed red blood cell transfused cannot be determined 
based on this retrospective study in which transfusion was 
performed without laboratory confirmation. 
In conclusion, the cephalhematoma size measured in 
the preoperative CT images is an independent risk factor 
for blood loss exceeding 30% of total body blood volume. 
Thus, we recommend implementing a transfusion strategy 
prior to pediatric cranioplasty based on cephalhematoma 
size measured by ImageJ as a new clinical model for intra-
operative transfusion management. 
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